mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
about
Genomic and molecular characterization of esophageal squamous cell carcinomaAssociations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.Rapamycin and thalidomide treatment of a patient with refractory metastatic gastroesophageal adenocarcinoma: a case report.Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysisPhosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus.Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma.Effect of PTEN antisense oligonucleotide on oesophageal squamous cell carcinoma cell lines.Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice.Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma.High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.Relation between outcomes and localisation of p-mTOR expression in gastric cancer.Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.Targeted treatments for metastatic esophageal squamous cell cancerA case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
P2860
Q28657686-21E19984-0747-44AC-A380-826AB0EBED83Q35053048-BF59BAB8-07F6-4F1B-BF46-84D7930FFC2AQ35584253-C1A52114-2966-4DE2-B736-5FE4DCBCE1F7Q36190276-9F6C71DA-AE74-4DD3-97BA-2C23D7EA8DA8Q36375220-5CEEDDA3-3B05-4007-90C7-D009BF7185F2Q37046569-6EE1EE23-7E1B-4CB5-A6D7-5F71894B718DQ37368400-4B12562E-76F1-4131-A9D1-6AEFE72EC091Q37566645-8DE2F866-53F7-45F6-9477-25D92219CF73Q38649673-B18D9F33-29BF-456C-B52C-B3A6E19D3402Q38664450-E5286529-6F4A-447A-AF47-530EE5017737Q39210082-B9F8FDB9-640F-473E-A928-69ABDC1E8B7EQ39215847-DFEE7588-3D25-4756-AD0B-0F0EBF644E56Q39396713-07796FEC-2583-416F-8FFB-7254A79F896DQ39821080-B95808F6-3440-4795-94FF-F7630FFA738AQ39933959-7C4AD674-8A9E-49BA-A9BE-2B1CDFD3EBC5Q41926168-205D4BFB-8C7E-4B2B-9A02-9437905C326EQ42131289-EE641B0C-38E5-4D8F-8653-AC5E9EA09A3BQ42154615-1575EE8A-3D2C-4AC7-82CB-CE26CE13EB42Q50446436-EA8837F4-86A0-418E-9357-1F668391883F
P2860
mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
mTOR in squamous cell carcinom ...... target for molecular therapy?
@en
mTOR in squamous cell carcinom ...... target for molecular therapy?
@nl
type
label
mTOR in squamous cell carcinom ...... target for molecular therapy?
@en
mTOR in squamous cell carcinom ...... target for molecular therapy?
@nl
prefLabel
mTOR in squamous cell carcinom ...... target for molecular therapy?
@en
mTOR in squamous cell carcinom ...... target for molecular therapy?
@nl
P2093
P356
P1476
mTOR in squamous cell carcinom ...... target for molecular therapy?
@en
P2093
F J W Ten Kate
G J A Offerhaus
I H M Borel Rinkes
P J van Diest
R van Hillegersberg
P304
P356
10.1136/JCP.2008.055772
P407
P577
2008-05-12T00:00:00Z